Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors
Authors:
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- Does Adjuvant Therapy Work in Colon Cancer?New England Journal of Medicine, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Phase I study of a 120‐hour continuous intravenous infusion of 5‐fluorouracil in pediatric patients with recurrent solid tumors: A pediatric oncology group studyMedical and Pediatric Oncology, 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- 5-Fluorouracil and Folinic Acid: Summary of Clinical Experience1988
- Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomasBiochemical Pharmacology, 1986
- Epidemic Colon Cancer in Children and Adolescents?1982
- 5-Fluorouracil1970
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957